To this point, studies evaluating the role of JAKinibs and JAK/STAT pathways in autoimmune diseases mainly investigated their anti-inflammatory effects, which are partly the results of their ability to modulate the activation state of pro-inflammatory macrophages by down-regulating IFNβ signature and IL-6 expression. The gene discussed is SOAT1; the disease is autoimmune disease.